CUSIP: 10778Y112
What is CUSIP 10778Y112?
CUSIP 10778Y112 identifies BCTXW - BriaCell Therapeutics Corp. - *W EXP 02/26/202 in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Open recent reporting periods for CUSIP 10778Y112:
As of 31 Dec 2025, 6 institutional investors reported holding 197,248 shares of BriaCell Therapeutics Corp. - *W EXP 02/26/202 (BCTXW).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 197,248 | $8,314 | +$4,968 | $0.05 | 6 |
| 2025 Q3 | 94,264 | $2,970 | -$4,016 | $0.03 | 3 |
| 2025 Q2 | 176,057 | $12,658 | +$1,076 | $0.08 | 6 |
| 2025 Q1 | 150,673 | $15,137 | -$31,484 | $0.10 | 7 |
| 2024 Q4 | 457,213 | $128,608 | -$6,543 | $0.26 | 4 |
| 2024 Q3 | 479,858 | $196,742 | +$7,804 | $0.41 | 4 |
| 2024 Q2 | 460,823 | $120,931 | +$2,696 | $0.25 | 4 |
| 2024 Q1 | 450,800 | $608,540 | +$1,040 | $1.30 | 3 |
| 2023 Q4 | 450,000 | $1,125,000 | -$111,501 | $2.50 | 2 |
| 2023 Q3 | 495,142 | $1,217,751 | -$330,261 | $2.47 | 4 |
| 2023 Q2 | 628,792 | $1,568,112 | -$281,329 | $2.50 | 5 |
| 2023 Q1 | 742,835 | $2,189,789 | -$1,773,750 | $2.96 | 4 |
| 2022 Q4 | 1,546,452 | $3,292,139 | +$77,916 | $2.06 | 8 |
| 2022 Q3 | 1,510,550 | $4,258,000 | +$288,867 | $2.87 | 7 |
| 2022 Q2 | 1,402,413 | $3,642,000 | +$551,681 | $2.60 | 7 |
| 2022 Q1 | 1,174,328 | $6,106,000 | +$893,730 | $5.20 | 9 |
| 2021 Q4 | 1,002,359 | $4,637,000 | +$429,926 | $4.69 | 5 |
| 2021 Q3 | 905,717 | $4,314,000 | +$843,759 | $4.77 | 8 |
| 2021 Q2 | 877,918 | $1,580,000 | -$591,218 | $1.80 | 10 |
| 2021 Q1 | 1,109,936 | $1,188,000 | +$1,188,000 | $1.07 | 6 |